CEL SCI CORP (CVM)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
15.11.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECion 13(a) of the Exchange Act. ☐         Item 5.02. Departure of Directors or Certain Officers; Election of Directors; A
23.04.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECon 13(a) of the Exchange Act.  ☐         Item 5.02. Departure of Directors or Certain Officers; Election of Directors; A
30.10.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECntry into a Material Definitive Agreement.   See Item 5.02 of this report.   Item 5.02. Departure of Directors or Certai
31.08.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECntry into a Material Definitive Agreement.   See Item 5.02 of this report.   Item 5.02. Departure of Directors or Certai

Stammdaten

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Unternehmen & Branche

NameCEL SCI CORP
TickerCVM
CIK0000725363
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2836 · Biological Products, (No Diagnostic Substances)

Wertpapier & Kennzahlen

CUSIP150837409
ISINUS1508374097
TypCommon Stock
Marktkapitalisierung21,2 Mio. USD
Beta1,00
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-Q-5,469,446-0.6822,894,67511,138,654
2025-09-3010-K-25,411,055-6.2728,155,74815,957,085
2025-06-3010-Q-5,664,704-1.3620,336,1997,024,940
2025-03-3110-Q-6,572,389-0.0821,807,3337,997,855
2024-12-3110-Q-7,073,062-3.2525,698,78711,308,632
2024-09-3010-K-26,920,465-15.3126,991,76612,867,083
2024-06-3010-Q-6,856,558-4.1824,068,3208,473,057
2024-03-3110-Q-7,244,891-0.1430,048,10514,304,643
2023-12-3110-Q-6,709,524-0.1428,710,21512,650,260
2023-09-3010-K-32,365,855-0.7330,528,25013,214,890
2023-06-3010-Q-8,367,28132,318,96814,789,399
2023-03-3110-Q-8,342,80938,195,24320,147,600
2022-12-3110-Q-7,853,509-0.1844,557,73726,591,621
2022-09-3010-K-36,700,681-0.8750,523,70632,163,207
2022-06-3010-Q-9,632,584-0.2356,889,79238,728,363
2022-03-3110-Q-9,823,492-0.2364,160,64645,127,548
2021-12-3110-Q-8,782,606-0.2069,671,73951,351,455
2021-09-3010-K-36,361,109-0.9075,869,96556,534,226
2021-06-3010-Q-8,938,268-0.2579,641,72659,793,744
2021-03-3110-Q-11,281,120-0.2848,365,17129,331,792

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
VANGUARD GROUP INC285,1170285,1171,499,715Neu+100,0%
MAI Capital Management89,723089,723471,943Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC79,183079,183416,523Neu+100,0%
BlackRock, Inc.43,261043,261227,553Neu+100,0%
BANK OF AMERICA CORP /DE/40,993040,993215,623Neu+100,0%
STATE STREET CORP25,570025,570134,498Neu+100,0%
COMMONWEALTH EQUITY SERVICES, LLC21,683021,683114,048Neu+100,0%
NORTHERN TRUST CORP18,698018,69898,351Neu+100,0%
US BANCORP \DE\18,413018,41396,852Neu+100,0%
OSAIC HOLDINGS, INC.18,309018,30996,296Neu+100,0%
JANE STREET GROUP, LLC15,707015,70782,619Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC15,406015,40681,036Neu+100,0%
UBS Group AG13,193013,19369,394Neu+100,0%
XTX Topco Ltd12,507012,50765,787Neu+100,0%
CITADEL ADVISORS LLC11,806011,80662,100Neu+100,0%
CHILTON CAPITAL MANAGEMENT LLC5,21105,21127,410Neu+100,0%
JPMORGAN CHASE & CO1,66701,6678,769Neu+100,0%
WELLS FARGO & COMPANY/MN76607664,029Neu+100,0%
Steward Partners Investment Advisory, LLC68606863,608Neu+100,0%
Hilton Head Capital Partners, LLC45004502,367Neu+100,0%
Tower Research Capital LLC (TRC)36403641,915Neu+100,0%
AdvisorNet Financial, Inc97097510Neu+100,0%
Fortitude Family Office, LLC75075395Neu+100,0%
MORGAN STANLEY59059310Neu+100,0%
BNP PARIBAS FINANCIAL MARKETS41041216Neu+100,0%
ALERUS FINANCIAL NA38038200Neu+100,0%
GABLES CAPITAL MANAGEMENT INC.26026137Neu+100,0%
HUNTINGTON NATIONAL BANK1601684Neu+100,0%
HRT FINANCIAL LP11,538011,53860Neu+100,0%
SBI Securities Co., Ltd.60632Neu+100,0%
SageView Advisory Group, LLC60632Neu+100,0%
Allworth Financial LP40422Neu+100,0%
Physician Wealth Advisors, Inc.30316Neu+100,0%
Navalign, LLC30316Neu+100,0%
Golden State Wealth Management, LLC30316Neu+100,0%
ROYAL BANK OF CANADA620620Neu+100,0%

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-01-22KERSTEN GEERT RDirector, Officer, Chief Executive OfficerOpen Market Purchase38,0235.26200,000.98+170,2%
2025-12-04KERSTEN GEERT RDirector, Officer, Chief Executive OfficerOpen Market Purchase8,3895.9649,998.44+42,6%
2025-07-25KERSTEN GEERT RDirector, Officer, Chief Executive OfficerOpen Market Purchase29,1976.85199,999.45+170,2%
2025-07-25Watson Robert EugeneDirectorOpen Market Purchase2,9196.8519,995.15+17,0%

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
VANGUARD GROUP INC285,1171,499,71539.65
MAI Capital Management89,723471,94312.48
GEODE CAPITAL MANAGEMENT, LLC79,183416,52311.01
BlackRock, Inc.43,261227,5536.02
BANK OF AMERICA CORP /DE/40,993215,6235.70
STATE STREET CORP25,570134,4983.56
COMMONWEALTH EQUITY SERVICES, LLC21,683114,0483.02
NORTHERN TRUST CORP18,69898,3512.60
US BANCORP \DE\18,41396,8522.56
OSAIC HOLDINGS, INC.18,30996,2962.55
JANE STREET GROUP, LLC15,70782,6192.18
RENAISSANCE TECHNOLOGIES LLC15,40681,0362.14
UBS Group AG13,19369,3941.83
XTX Topco Ltd12,50765,7871.74
CITADEL ADVISORS LLC11,80662,1001.64
CHILTON CAPITAL MANAGEMENT LLC5,21127,4100.72
JPMORGAN CHASE & CO1,6678,7690.23
WELLS FARGO & COMPANY/MN7664,0290.11
Steward Partners Investment Advisory, LLC6863,6080.10
Hilton Head Capital Partners, LLC4502,3670.06

Hinweis

Erweitert ×